Posted on 3/24/20
IASO Biotherapeutics Raises $60 Million in Series B
IASO Biotherapeutics (IASO BIO) today announced the completion of $60 million in series B financing led by GL Ventures, which is a venture capital fund of . . .
Posted on 3/24/20
Most Aggressive States Against the Coronavirus – WalletHub Study
According to the World Health Organization, the primary way that coronavirus (COVID-19) spreads is through close interaction with other people. If people come into contact with . . .
Posted on 3/24/20
Why Berkshire Hathaway, Lockheed Martin, and Harley-Davidson Stocks All Dropped This Morning
What happenedOver the weekend, congressional and White House plans for a quick bailout of companies crushed by coronavirus and a quick mail-out of cash checks to . . .
Posted on 3/24/20
Are These Warren Buffett Stocks a Buy at Beaten-Down Prices?
Warren Buffett's holding company Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) has been able to produce jaw-dropping gains for its shareholders over the years by adhering to three basic . . .
Posted on 3/24/20
Why Raytheon, General Dynamics, and United Technologies Stocks All Fell 10% Today
What happenedCongressional and White House plans to bail out companies crushed by the novel coronavirus and to mail out billions of dollars' worth of relief cash . . .
Posted on 3/24/20
New York to Start Clinical Trials of Anti-Malaria Drugs for COVID-19
As the number of COVID-19 cases continues to rise across the U.S., many state authorities are trying anything they can to address the health crisis.On Tuesday, . . .
Posted on 3/24/20
Eyenovia Announces Approximately $6.0 Million Private Placement
NEW YORK, March 23, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its . . .
Posted on 3/23/20
Hoth Therapeutics Announces Proposed Public Offering of Common Stock
Hoth Therapeutics Inc. (Nasdaq: HOTH), a biopharmaceutical company, today announced that it intends to offer shares of its common stock in a "best efforts" underwritten public . . .
Posted on 3/23/20
DLA Piper launches Coronavirus Resource Center
DLA Piper has launched a Coronavirus Resource Center (CRC) to serve as a central repository for companies across jurisdictions and industries as they deal with the . . .
Posted on 3/23/20
Fortress Biotech Announces Up to $5M Series A Cumulative Redeemable Perpetual Preferred Stock Repurchase Program
NEW YORK, March 23, 2020 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO), an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential marketed pharmaceutical . . .
Posted on 3/23/20
Hoth Therapeutics Announces Agreement to Joint Development of a Self-Assembling Vaccine
NEW YORK, March 23, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has reached an agreement with Voltron Therapeutics, Hoth . . .
Posted on 3/23/20
Pfizer Is A Buy Now
SummaryPfizer's share price is currently 33% below fair value.It is a financially robust firm that will continue to be profitable.Its strong pipeline assures its future profitability.Pfizer . . .
Posted on 3/23/20
Johnson and Johnson: A Safe Haven in Recession
In general, a recession occurs when the economy declines because people are buying fewer goods and services. With temporary business closures all over the world, recession . . .
Posted on 3/23/20
Why Is Everyone Talking About Regeneron?
People in the biotech world have talked about Regeneron Pharmaceuticals (NASDAQ:REGN) for a long time. After all, the company has achieved a lot of success over . . .
Posted on 3/20/20
National Kidney Foundation Honors Janssen Pharmaceutical Companies of Johnson & Johnson with 2020 Corporate Innovator Award
Janssen Pharmaceuticals Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson has been selected to receive the 2020 Corporate Innovator Award from the National . . .
Posted on 3/20/20
Applied DNA Secures Global Top-20 Pharmaceutical Manufacturer as Drug Development Customer
STONY BROOK N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability . . .
Posted on 3/20/20
Chembio Diagnostics Receives $4M Purchase Order from Bio-Manguinhos
HAUPPAUGE, N.Y., March 20, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced its receipt . . .
Posted on 3/20/20
Mylan Ramps Up Production of Hydroxychloroquine as a Potential COVID-19 Treatment
Mylan (NASDAQ:MYL) has restarted production of its hydroxychloroquine sulfate tablets at its West Virginia manufacturing facility as a potential treatment for COVID-19, the disease caused by . . .
Posted on 3/20/20
GE Healthcare Boosts Its COVID-19 Efforts
GE Healthcare President and CEO Kieran Murphy issued a statement Thursday detailing the company's efforts to help the world battle the coronavirus pandemic. The unit of . . .
Posted on 3/20/20
Bristol Myers Squibb Hints at Further Acquisition Plans With New Executive Hire
Bristol Myers Squibb (NYSE:BMY) is drawing from the ranks of the finance industry for its latest high-level hire. The company announced Wednesday it has tapped Elizabeth . . .
Posted on 3/19/20
2020 Women on Boards Honors Tabula Rasa HealthCare for Having at Least 20% Women on its Corporate Board
MOORESTOWN, N.J ., March 19, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC). 2020 Women on Boards, the premier global education and advocacy campaign . . .
Posted on 3/19/20
Trump Signs Coronavirus Relief Bill Into Law
After hammering out the details regarding the coronavirus relief package proposed by the Trump administration, the Senate approved the bill on Wednesday, with President Trump signing . . .
Posted on 3/19/20
Cigna Reports Pricing Of $1.45B Of Notes Under Tender Offers
Cigna (NYSE:CI) gives pricing terms for $1.45B of notes tendered under its previously announced tender offers. Total consideration includes $30 early tender payment per $1,000 principal . . .
Posted on 3/19/20
J&J Files U.S. Application For MS Med Ponesimod
Johnson & Johnson (NYSE:JNJ) unit Janssen Pharmaceutical Companies has submitted a marketing application to the FDA for ponesimod for adults with relapsing multiple sclerosis (MS).MS is . . .
Posted on 3/19/20
Pfizer's Abrocitinib Successful In Dermatitis Study
A Phase 3 clinical trial, JADE COMPARE, evaluating Pfizer's (NYSE:PFE) JAK1 inhibitor abrocitinib in patients with moderate-to-severe atopic dermatitis met both co-primary endpoints of response rate . . .
New York
